ArticleJournal of clinical medicine2022

Real-World Efficacy of Regdanvimab on Clinical Outcomes in Patients with Mild to Moderate COVID-19.

Taeyun Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.